Which breathing aid works best after extubation? new study compares NIV and HFNC
NCT ID NCT07630766
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 102 adults in the intensive care unit who were at high risk of needing a breathing tube again after it was removed. Researchers compared two types of breathing support: noninvasive ventilation (a mask that helps push air into the lungs) and high-flow nasal cannula (warm, moist air delivered through the nose). The goal was to see which method better prevents the need to put the breathing tube back in. The study found which approach led to fewer reinsertions and better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
102 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
inclusion criteria 1. Age ≥18 years. 2. Received invasive mechanical ventilation for at least 24 hours. 3. Considered ready for planned extubation after successful completion of a spontaneous breathing trial. 4. High risk of extubation failure, defined by the presence of at least four of the following risk factors: Age \>65 years. APACHE II score \>12 on the day of extubation. Body mass index \>30 kg/m². Inadequate secretion management. Difficult or prolonged weaning. Two or more comorbidities. Acute heart failure requiring mechanical ventilation. Moderate-to-severe chronic obstructive pulmonary disease. Airway patency problems. Prolonged mechanical ventilation. Hypercapnia at the end of the spontaneous breathing trial. Exclusion Criteria: 1. Age \<18 years. 2. Presence of a tracheostomy. 3. Accidental extubation. 4. Self-extubation. 5. Contraindication to noninvasive ventilation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extubation failure are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benha University Hospital
Banhā, Qalyubia Governorate, 13511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple ultrasound predict which newborns breathe on their own?
- A simple cough measurement may help doctors decide when to safely remove a breathing tube
- Could a diaphragm sensor help preemies breathe on their own sooner?
- Warm oxygen through the nose may help brain injury patients breathe easier after ventilator
- Simple swallow check may predict ventilator weaning failure
- New study aims to predict which ICU patients need breathing tubes again